ARS Pharmaceuticals, Inc.

SPRY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jul 2, 2026
4 Jun 26, 2026
4 Jun 26, 2026 4
4 Jun 26, 2026
4 Jun 26, 2026
4 Jun 26, 2026
4 Jun 26, 2026
4 Jun 26, 2026
4 Jun 26, 2026
4 Jun 26, 2026
8-K Jun 25, 2026 8-K
4 Jun 12, 2026
4 Jun 12, 2026
144 Jun 12, 2026
144 Jun 12, 2026
3 Jun 1, 2026
SCHEDULE 13G/A May 15, 2026
10-Q May 15, 2026 10-Q
8-K May 15, 2026 8-K
8-K May 13, 2026 8-K
ARS Apr 29, 2026 ARS
DEFA14A Apr 29, 2026 DEFA14A
DEF 14A Apr 29, 2026 DEF 14A
SCHEDULE 13G/A Apr 27, 2026
SCHEDULE 13G/A Mar 31, 2026
← Newer Page 2 of 22 · 544 filings Older →